Cri Lifetree

Philadelphia, Pennsylvania 19139

0 studies enrolling now · 13 studies all time

What they study most

Adult Attention Deficit Hyperactivity Disorder, B Vitamin Deficiency, Binge Eating Disorder, Diabetic Peripheral Neuropathy, Fibromyalgia, Hepatitis C, Mental Disorder, Nervous System Diseases, Neuropathic Pain, Pain, Schizoaffective Disorder, Schizophrenia

Studies at this site

• SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating Disorder — Completed
• Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia — Stopped early
• SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia — Stopped early
• Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain — Completed
• A Study of Duloxetine in Adolescents With Juvenile Primary Fibromyalgia Syndrome — Completed
• Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients — Completed
• Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film — Completed
• Lurasidone Low-Dose - High-Dose Study Study — Completed
• The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN) — Status unconfirmed
• Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia — Completed
• Bioavailability of LY03004 and Risperdal® Consta® — Completed
• Adult Attention Deficit Hyperactivity Disorder — Completed
• Drug Interaction & Methadone & Buprenorphine — Completed